CD109 Polyclonal Antibody

This gene encodes a glycosyl phosphatidylinositol (GPI)-linked glycoprotein that localizes to the surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signalling by transforming growth factor beta (TGF-beta). Multiple transcript variants encoding different isoforms have been found for this gene.

The CD109 Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection of CD109 protein in various biological samples. This antibody is produced using high-quality polyclonal antibodies that have been purified and validated for use in a wide range of applications, including Western blotting, immunohistochemistry, and flow cytometry.

The CD109 protein is a glycosylphosphatidylinositol (GPI)-anchored glycoprotein that is expressed on the surface of various cell types, including endothelial cells, smooth muscle cells, and fibroblasts. It has been shown to play a critical role in the regulation of cell proliferation, differentiation, and migration, as well as in the development and progression of various diseases, including cancer.

The CD109 Polyclonal Antibody is highly specific and sensitive, with minimal cross-reactivity to other proteins, ensuring accurate and reliable results. It is also highly reproducible, with consistent performance across multiple experiments and samples.

Overall, the CD109 Polyclonal Antibody is an essential tool for researchers studying the role of CD109 in various biological processes and diseases. Its high specificity, sensitivity, and reproducibility make it an ideal choice for a wide range of applications, from basic research to clinical diagnostics.